Investor Essentials Daily

Don’t let this rally fool you about Chinese stocks

March 24, 2025

Chinese tech stocks have rallied over 35% this year, thanks in part to new AI breakthroughs and government stimulus. 

However, rising default risks and mounting debt point to deeper structural issues, making this surge look more like a “dead cat bounce.” 

Over the long haul, U.S. stocks have shown more consistent gains, and given China’s ongoing problems, its market remains too risky for fundamental, long-term investors.

Investor Essentials Daily:
The Monday Macro Report
Powered by Valens Research

The Hang Seng Tech Index, which tracks the 30 biggest Hong Kong-listed tech stocks, is up roughly 35% year-to-date.

The tech-heavy Nasdaq Composite Index is down more than 5% in the same period. And the “Magnificent 7” alone are down around 13%.

A major driver of this surge is DeepSeek, the Chinese AI breakthrough that surprised global markets earlier this year. It raised investors’ hopes that China’s tech sector might be more competitive than expected.

The Chinese government has also promised sweeping financial stimulus to boost the economy.

Since September, the government has cut interest rates including on mortgages, urged business leaders to increase spending and pushed wage increases for workers.

On the other hand, U.S. stocks have struggled under the weight of tariff uncertainty and the risk of inflation.

These differences might make China seem like a better market to invest in than the U.S. 

However, China still has plenty of problems and the recent stock gains don’t erase them.

Chinese companies had major default risk at twice the rate of U.S. companies towards the end of the last year.

Despite the stock market rally since then, that number has risen even further… from 6% to 8% of Chinese companies at risk today.

And unlike in U.S. markets, where struggling companies face bankruptcy or restructuring, the Chinese government offers up more debt to keep up the appearance of growth.

This is driving the debt loads of Chinese firms higher, creating a cycle of delayed defaults and mounting financial pressure.

The recent rally in Chinese stocks looks more like a ‘dead cat bounce’ than anything sustainable.

Said another way, this doesn’t look like the beginning of a bull rally, it looks like the market’s last signs of life.

This is far from the first time we’ve seen short-term gains in China.

Take a look at the following chart. It compares the return of the benchmark Shanghai Index with the Dow Jones Industrial Average from 2008 to 2024.

As you can see, the Dow has surged more than 300% since 2008. And that growth has been strong and consistent, despite significant downside in periods like the 2008 Financial Crisis and the COVID-19 pandemic.

On the other hand, the Shanghai Index has remained relatively flat over the past 16 years.

Check it out…


Even with the recent rally, Chinese stocks far underperform the U.S. market. Despite being masked by a short-term surge in stocks, China still has huge problems.

In fact, despite the government trying to encourage investors with financial stimulus, all of that looks like it’s hurting companies by saddling them with even more debt. 

This cannot go on forever… eventually, wider-spread bankruptcies will ensue.

As long as the structural problems of China don’t disappear, the Chinese stock market is suitable for folks capitalizing on volatility.

However, with the existing conditions, China is still uninvestable for fundamental long-term investors.


Best regards,

Joel Litman & Rob Spivey
Chief Investment Officer &
Director of Research
at Valens Research

View All

You don’t have access to the Valens Research Premium Application.

To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email client.relations@valens-research.com.

Please fill out the fields below so that our client relations team can contact you

Or contact our Client Relationship Team at 630-841-0683